$MRVL

MURPHY MATTHEW J sold $1.8M of MRVL

MURPHY MATTHEW J (Chairman of the Board and CEO) sold 7,500 shares of Marvell Technology, Inc. (MRVL) at $236.08 ($1.77M total) on 2026-08-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MURPHY MATTHEW J
Published Aug 18, 2026, 12:59 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MRVL
Neutral
high confidence
Mentioned
$MRVL
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRVLNeutralLow
01

Why it matters

The disclosed sale amount is material in dollar terms but is explicitly under a pre-arranged 10b5-1 plan, which generally makes it less informative about immediate company outlook.

02

Market read

Traders may briefly reassess sentiment around MRVL due to insider selling, but the 10b5-1 framing reduces the likelihood of a fundamental repricing.

03

What to watch

The article does not state whether other insiders sold, whether there were concurrent option exercises, or whether the sale was part of broader liquidity needs, limiting inference.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-17 for a sale executed 2026-08-17

Background

This is an SEC Form 4 insider transaction disclosure for Marvell Technology, Inc.

Company-level read

Ticker impact

$MRVLNeutralHigh confidence
Context

Marvell CEO and Chairman Matthew J. Murphy sold 7,500 shares in an open-market transaction for about $1.77M under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

Form 4 details a single open-market sale by an insider, explicitly tied to a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider transaction data.

None.

None.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with internal expectations of weaker near-term performance, so traders may watch for follow-on disclosures.

Key entities

  • Marvell Technology, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Matthew J. Murphy

    Chairman of the Board and CEO who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TSMMedAI 8/10

Marvell Technology and Taiwan Semiconductor are No-Brainer Picks: They Have What Wins in a Gold Rush

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, positioning them as key players in AI infrastructure. TSM's Q2 2026 revenue rose 36% YoY to $40.2B, with advanced nodes driving 77% of wafer revenue. MRVL's Q2 2027 revenue increased 36.5% YoY to $2.74B, with data center revenue up 46% YoY. Both companies are seen as essential for AI development, with TSM benefiting from broad industry demand and MRVL tied to hyperscaler custom silicon cycles.

$TSMHighAI 8/10

Marvell Technology and Taiwan Semiconductor are No

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, with TSM posting $40.20B revenue and $4.31 EPS, while MRVL saw 36.5% revenue growth and 46% data center revenue increase. TSM's advanced nodes drove 77% of wafer revenue, and MRVL's custom silicon business is expected to double by fiscal 2028. Both companies are key players in AI infrastructure.

$MRVLMedAI 8/10

Marvell stock is down 36% from recent all-time highs; can it get its mojo back?

Marvell Technology (MRVL) shares have fallen 36% from their all-time high, trading at $213.33 in pre-market. Despite a 226% gain over the past year, the stock dropped 7.9% post-earnings due to margin compression concerns and deferred long-term guidance. The company reported Q2 revenue of $2.74B (+37% YoY) and raised FY2027 guidance to ~$12B. Analysts remain bullish, with targets up to $400, but bears cite margin pressures and potential AI capex slowdowns. Investor Day in October is a key catalys

$MRVLHighAI 8/10

MRVL Stock Heads For Worst Day In A Month After Q2: Analyst Sees Blue-Chip Customers, Broad Portfolio As Healthy Growth Signals

Marvell Technology (MRVL) shares fell 8.2% premarket after Q2 results, despite a new AI chip deal with Google. Analysts highlighted its blue-chip customers and diversified portfolio as growth drivers. Morningstar raised its price target to $300, while Goldman Sachs maintained a 'Neutral' rating with a $195 target. MRVL reported $2.74B in sales, up 37%, and raised fiscal 2028 sales guidance to $18B.